Live Biotherapeutic Products Whitepaper 2025
Growth in LBP production can be attributed to well-defined regulatory pathways in regions such as the US and EU, advancements…
Growth in LBP production can be attributed to well-defined regulatory pathways in regions such as the US and EU, advancements…
The brand-new edition of the 2026 Clinical Research Report examines key therapy areas and deep dives into the latest advances…
Author: Manny Vazquez, Senior Director Clinical Data Strategy, Veeva The number of data points collected in clinical trials has tripled…
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
In the fast-paced environment of pharmaceutical innovation, bioconjugation has proved to be a cornerstone technology. By enabling the precise modification…
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
In the US alone, over 7,000 different rare diseases affect more than 30 million people[i]. Many of these conditions are…
What are Alum Products, and why are they challenging to fill? Alum products, commonly referring to aluminum-based adjuvants, play a…
The biotech industry is experiencing an unprecedented transformation, marked by complex market dynamics, shifting global innovation patterns and evolving investment…
In a recent webinar, Marc McArdle, CLA Customer Success Manager, was joined by Jackie Marchington, Head of Compliance and Ethics…